Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

Frederick S. Barrett, Yun Zhou, Theresa M. Carbonaro, Joshua Roberts, Gwenn S. Smith, Roland R. Griffiths, Dean F. WongFrontiers in Neuroergonomics 2022 · DOI

TL;DR

This pilot study uses a high-resolution combination of PET imaging and fMRI-based brain mapping to quantify exactly where psilocybin binds to serotonin 2A (5-HT$_{2A}$) receptors. The researchers found that a standard psychoactive dose occupies roughly 40% of these receptors across the cortex, with the highest engagement occurring in the "Default Mode Network"—the brain regions associated with self-reflection and the "ego."

What Problem Does This Paper Address?

While psilocybin is gaining clinical traction for treating depression and substance use disorders, our understanding of its molecular "target engagement" in the human brain remains somewhat coarse. We know psilocybin’s primary mechanism is agonism of the 5-HT$_{2A}$ receptor, but we haven't had a high-resolution, regional map of how much of the drug actually binds to these receptors across different functional areas of the cortex.

Previous studies often looked at the neocortex as a whole or used anatomical atlases that don't necessarily reflect how the brain is functionally organized. This paper addresses that gap by combining molecular imaging (PET) with functional brain parcellation (fMRI) to see if psilocybin targets specific functional networks more than others.

Methods

The study followed four healthy volunteers through a rigorous imaging protocol:

  1. Resting-State fMRI Parcellation: Before any drug administration, researchers used fMRI to map each participant's functional brain connectivity. They divided the cortex into 200 "parcels" or regions of interest (ROIs) based on how areas naturally communicate with each other, rather than just using standard anatomy.
  2. PET Imaging with [$^{11}$C]MDL 100,907: This is the "gold standard" radioligand for 5-HT$_{2A}$ receptors. It acts as an inverse agonist, meaning it competes with psilocybin for the same receptor sites.
  3. The Protocol: Participants underwent a baseline PET scan, then received an oral dose of psilocybin (10 mg/70 kg). A second "blocking" PET scan was performed 80 minutes later, timed to coincide with the estimated peak plasma concentration ($C_{max}$) of psilocin (the active metabolite).
  4. Quantification: By comparing the baseline scan to the post-psilocybin scan, the team calculated the "occupancy"—the percentage of receptors "blocked" or occupied by the psilocybin.

Datasets

  • Primary Data: High-resolution structural MRI, resting-state fMRI, and dynamic PET scans from 4 healthy volunteers (2 male, 2 female; mean age 28).
  • Reference Region: The cerebellum was used as a reference region for PET analysis because it contains negligible levels of 5-HT$_{2A}$ receptors.

Key Insights and Ideas

  • The DMN Connection: The most striking finding was that the regions with the highest receptor occupancy (63% to 75%) were located within the Default Mode Network (DMN)—specifically the subgenual anterior cingulate and bilateral angular gyri. Since the DMN is heavily implicated in self-referential thought and the "narrative self," this provides a molecular link to why psilocybin causes "ego dissolution."
  • Individual Variability: Despite a standardized dose based on body weight, the researchers observed "marked individual variability." In the left angular gyrus, for example, occupancy ranged from 48.5% in one subject to 90.5% in another. This suggests that the same dose can lead to vastly different levels of brain engagement across individuals.
  • Methodological Synergy: By using fMRI-derived ROIs instead of anatomical ones, the researchers were able to interrogate 5-HT$_{2A}$ occupancy in a way that is more relevant to current theories of psychedelic action, which focus on changes in functional connectivity.

Key Results

  • Average Occupancy: Across all 137 retained cortical ROIs, the average 5-HT$_{2A}$ receptor occupancy was 39.5% (± 10.9% SD).
  • Peak Occupancy: The highest regional occupancy was found in the left angular gyrus (74.72%).
  • Baseline Binding: The average baseline binding potential ($BP_{ND}$) was 1.44 (± 0.33 SD), confirming the ligand's effectiveness in mapping receptor density before drug intervention.
  • Time-Activity Curves: PET data showed substantial "blocking" of the radioligand in the angular gyrus after psilocybin administration, while the cerebellum remained unaffected, validating the specificity of the measurement.

Limitations and Future Work

  • Sample Size: As a pilot study with only four participants, the statistical power is limited. The authors emphasize that these results are preliminary.
  • Dose-Response: The study only tested one dose (10 mg/70 kg). Future research needs to explore a wider range of doses to establish a full dose-occupancy curve.
  • Genetics and Metabolism: The study did not account for genetic polymorphisms (like the 5-HT$_{2A}$ $His452Tyr$ variant) or individual metabolic rates, which likely contribute to the observed variability in occupancy.
  • Clinical Correlation: The next step is to correlate these regional occupancy maps with subjective "mystical experience" scores and long-term clinical outcomes in patients with depression or anxiety.

Summary updated

Abstract

Psilocybin (a serotonin 2A, or 5-HT<sub>2A</sub>, receptor agonist) has shown preliminary efficacy as a treatment for mood and substance use disorders. The current report utilized positron emission tomography (PET) with the selective 5-HT<sub>2A</sub> receptor inverse agonist radioligand [<sup>11</sup>C]MDL 100,907 (a.k.a. M100,907) and cortical regions of interest (ROIs) derived from resting-state functional connectivity-based brain parcellations in 4 healthy volunteers (2 females) to determine regional occupancy/target engagement of 5-HT<sub>2A</sub> receptors after oral administration of a psychoactive dose of psilocybin (10 mg/70 kg). Average 5-HT<sub>2A</sub> receptor occupancy across all ROIs was 39.5% (± 10.9% SD). Three of the ROIs with greatest occupancy (between 63.12 and 74.72% occupancy) were within the default mode network (subgenual anterior cingulate and bilateral angular gyri). However, marked individual variability in regional occupancy was observed across individuals. These data support further investigation of the relationship between individual differences in the acute and enduring effects of psilocybin and the degree of regional 5-HT<sub>2A</sub> receptor occupancy.
BibTeX
@inproceedings{barrett2022human,
  author = {Frederick S. Barrett and Yun Zhou and Theresa M. Carbonaro and Joshua Roberts and Gwenn S. Smith and Roland R. Griffiths and Dean F. Wong},
  title = {{Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation}},
  booktitle = {Frontiers in Neuroergonomics},
  year = {2022},
  doi = {10.3389/fnrgo.2021.784576},
}
Figure